Royce & Associates’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-537	Closed	-$5K	–	1215
2018 Q1	$5K	Buy	537 +190	+55%	+$1.77K	﹤0.01%	1239
2017 Q4	$5K	Buy	347 +100	+40%	+$1.44K	﹤0.01%	1234
2017 Q3	$5K	Buy	+247	New	+$5K	﹤0.01%	1225